Search Results

CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions.

https://www.cslbehring.co.uk/research-and-development

CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.

https://www.cslbehring.co.uk/our-company

CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.

https://www.cslbehring.co.uk/home

CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide.

https://www.cslbehring.co.uk/

Seqirus operates state-of-the-art production facilities in the US, the United Kingdom (UK) and Australia, and utilises both egg-based and cell-based Research and Development manufacturing technologies as well as a Manufacturing proprietary adjuvant.

https://www.cslbehring.co.uk/-/media/cslb-uk/documents/csl-statement-on-modern-slavery-2020.pdf

Interview with Chief Scientific Officer Andrew Nash

https://www.cslbehring.co.uk/news/news-2020/andrew-nash

CSL Behring is committed to support Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they are designed to treat.

https://www.cslbehring.co.uk/research-and-development/iis

CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.

https://www.cslbehring.co.uk/our-company/coronavirus-information

Here you will find the range of pharmaceutical products that we offer in the UK for immunodeficiency, haemophilia, and other rare and serious diseases.

https://www.cslbehring.co.uk/products/product-range/educational-websites

CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions.

https://www.cslbehring.co.uk/research-and-development/prof-heimburger-award